Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Trifluridine/Tipiracil (FTD/TPI (TAS-102)) in Biliary Tract Cancers

NCT03278106 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT03278106
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03278106 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Trifluridine/Tipiracil (FTD/TPI (TAS-102)) in Biliary Tract Cancers
Lead sponsor
Mayo Clinic
Phase
Phase 2
Overall status
Completed
Start date
October 20, 2017
Completion date
September 16, 2021
Enrollment
28 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cholangiocarcinoma, stage iii gallbladder cancer ajcc v7, stage iiia gallbladder cancer ajcc v7, stage iiib gallbladder cancer ajcc v7, stage iv gallbladder cancer ajcc v7, stage iva gallbladder cancer ajcc v7, stage ivb gallbladder cancer ajcc v7